Avita Medical announces Cohealyx data published in Journal of Surgery

Avita Medical (RCEL) announced the first clinical publication evaluating Cohealyx, an Avita Medical-branded collagen-based dermal matrix, published in the Journal of Surgery. According to the investigators, Cohealyx demonstrated significantly faster wound bed vascularization and autograft readiness compared to conventional dermal matrices, achieving readiness within five to 10 days versus the typical two to four weeks. In the case series conducted at The Ohio State University Wexner Medical Center, two patients with complex, full-thickness hand wounds were treated with Cohealyx. One patient achieved a well-vascularized wound bed by day five, enabling autografting by day 7. The second patient reached robust re-vascularization by day 10 and proceeded to autografting on day 13. Both patients had excellent skin graft take outcomes and functional recovery. According to the publication, these outcomes demonstrate accelerated integration and wound bed vascularization, potentially facilitating earlier definitive wound closure, which can significantly reduce patient burden and lower associated complication risks.